PlasmaBNP, a useful marker of fluid overload in hospitalized hemodialysis patients

Hemodialysis International

Volumn 16, Issue 1, 2012, Pages 47-52

  Çelik, Gülperi ^a   Silinou, Emilie ^b   Vo Van, Cyril ^b   Jean, Guillaume ^b   Chazot, Charles ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b NephroCare Tassin   (France)

Author keywords

BNP; Catabolism; CRP; Fluid overload; Inflammation; Prealbumin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PREALBUMIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY WEIGHT; CATABOLISM; CLINICAL ARTICLE; CONVALESCENCE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRY WEIGHT; FEMALE; FLUID OVERLOAD; HEMODIALYSIS PATIENT; HOSPITAL PATIENT; HUMAN; INFLAMMATION; INTOXICATION; MALE; MEDICAL RECORD REVIEW; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RETROSPECTIVE STUDY; BLOOD; BODY FLUID; HOSPITALIZATION; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY FLUIDS; C-REACTIVE PROTEIN; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS;

EID: 84856383916     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00627.x     Document Type: Article

References (24)

1. Ito S, Murai S, Sugiura M, Yoshida T, Fukutomi T. Predictors of congestive heart failure in patients on maintenance hemodialysis. Circ J. 2007; 71:1424-1429.
2. Hickman PE, McGill DA, Talaulikar G, etal. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J. 2009; 39:812-818.
3. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007; 50 2357-2368.
4. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. Biology of the natriuretic peptides. Am J Cardiol. 2008; 101:3-8.
5. Biasioli S, Zamperetti M, Borin D, Guidi G, De Fanti E, Schiavon R. Significance of plasma B-type natriuretic peptide in hemodialysis patients: Blood sample timing and comorbidity burden. ASAIO J. 2007; 53:587-591.
6. Roueff S, Martin E, Chauffert ML, etal. Brain natriuretic peptide variations are linked to volume status in hemodialysis patients. Clin Nephrol. 2008; 70:508-513.
7. Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005; 45:891-902.
8. Jacobs LH, van de Kerkhof JJ, Mingels AM, etal. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: A longitudinal study. Nephrol Dial Transplant. 2010; 25:243-248.
9. McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev. 2003; 8:355-358.
10. Omland T, Hagve TA. Natriuretic peptides: Physiologic and analytic considerations. Heart Fail Clin. 2009; 5:471-487.
11. Davidson NC, Struthers AD. Brain natriuretic peptide. J Hypertens. 1994; 12:329-336.
12. Mallamaci F, Zoccali C, Tripepi G, etal. CREED Investigators. The Cardiovascular Risk Extended Evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001; 59:1559-1566.
13. Chazot C, Vo-Van C, Zaoui E, etal. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident hemodialysis patients. Nephrol Dial Transplant. 2011; 26:2630-2634.
14. Cataliotti A, Malatino LS, Jougasaki M, etal. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc. 2001; 76:1111-1119.
15. Chazot C, Jean G, Vo-Van C, etal. The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients. Blood Purif. 2009; 28:187-192.
16. Fagugli RM, Palumbo B, Ricciardi D, etal. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003; 95:c60-c66.
17. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis. 2003; 41:1257-1266.
18. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial. 2002; 15:329-337.
19. Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010; 5:1036-1040.
20. de Bold AJ. Cardiac natriuretic peptides gene expression and secretion in inflammation. J Investig Med. 2009; 57:29-32.
21. Kapoun AM, Liang F, O'Young G, etal. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res. 2004; 94:453-461.
22. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000; 15:953-960.
23. Chazot C, Jean G. Intradialytic hypertension: It is time to act. Nephron Clin Pract. 2010; 115:c182-c188.
24. Parfrey PS. BNP in hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5:954-955.